Neurosurgery News and Research

RSS

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

31 Mar 2022

Studies provide a pathway to better understand the return of consciousness after TBI

The return of consciousness after traumatic brain injury (TBI) remains something of a mystery for scientists and is not easy to predict.

31 Mar 2022

New trial examines the effectiveness of a two-pronged immunotherapy for glioblastomas

A new clinical trial at the University of Cincinnati is studying the effectiveness of a new two-pronged immunotherapy treatment procedure to treat the most aggressive and deadly type of brain tumors, called glioblastomas. Originating from healthy brain cells, glioblastomas can form in any area of the brain.

25 Mar 2022

Researchers win NIH grant to treat human brain cancer with a drug previously used on canines

The National Institutes of Health is awarding a $3.8 million grant to John Rossmeisl, the Dr. and Mrs. Dorsey Taylor Mahin Professor of Neurology and Neurosurgery at the Virginia-Maryland College of Veterinary Medicine, and Waldemar Debinski, cancer biology professor at the Wake Forest School of Medicine.

21 Mar 2022

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a Phase 1, open-label, placebo-controlled study to evaluate the safety and immunogenicity of an egg-based COVID-19 vaccine in healthy, vaccinated adults who have never been infected with COVID-19.

21 Mar 2022

Mount Sinai Health System launches new Alopecia Areata Center of Excellence

In an unparalleled effort to deliver outstanding comprehensive care and to employ revolutionary approaches to novel therapeutics around the skin condition alopecia areata, the Mount Sinai Health System has launched the Alopecia Areata Center of Excellence.

21 Mar 2022

Study provides new understanding of how memory works when the brain sees a familiar face

In a study led by Cedars-Sinai, researchers have uncovered new information about how the area of the brain responsible for memory is triggered when the eyes come to rest on a face versus another object or image.

18 Mar 2022

UQ researchers discover a molecule essential for regulating nerve repair

Researchers at The University of Queensland have identified a molecule essential for regulating the repair of injured nerves, which could help people recover from nerve damage.

16 Mar 2022

Study identifies two types of brain cells involved in organizing discrete memories

Researchers have identified two types of cells in our brains that are involved in organizing discrete memories based on when they occurred.

7 Mar 2022

Study to examine the risks for brain disorders from repetitive head impacts in contact sports

Internationally-renowned researchers from Boston University and the University of California, San Francisco) are launching a new study, called the Head Impact & Trauma Surveillance Study (HITSS).

7 Mar 2022

Community-based approach to genetic testing may have beneficial effects, study finds

In 2010, scientists discovered that African Americans who are born with certain variants of a gene called apolipoprotein L1 (APOL1) have a higher-than-average risk for experiencing chronic kidney disease (CKD).

4 Mar 2022

Novel MRI approach can identify brain cell damage in people at early stages of Alzheimer's

Alzheimer's disease usually is diagnosed based on symptoms, such as when a person shows signs of memory loss and difficulty thinking.

2 Mar 2022

Aggressive brain tumor in children can be identified by analyzing cerebrospinal fluid

It may be possible to identify the presence of an aggressive brain tumor in children by studying their cerebrospinal fluid, according to new research led by Johns Hopkins Kimmel Cancer Center investigators.

2 Mar 2022

Researchers develop new precision medicine technology for cancer immunotherapy

In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionized areas of cancer care.

28 Feb 2022

Mapping cells to understand vascular disease

In this interview, we speak to Dr. Ethan Winkler and Dr. Tomasz Nowakowski about their latest research which illustrated the interplay between vascular and immune cells that contributes to brain hemorrhage.

25 Feb 2022

Study reveals the various ways patients with multiple sclerosis acquire disability

A new study conducted by researchers from the Corrine Goldsmith Dickinson Center for Multiple Sclerosis at Icahn School of Medicine at Mount Sinai in collaboration with Novartis, the University of Oxford and key MS experts across the globe, has revealed detailed information on the various ways patients with multiple sclerosis (MS) acquire disability.

23 Feb 2022

Neurosurgery News and Research

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Studies provide a pathway to better understand the return of consciousness after TBI

New trial examines the effectiveness of a two-pronged immunotherapy for glioblastomas

Researchers win NIH grant to treat human brain cancer with a drug previously used on canines

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

Mount Sinai Health System launches new Alopecia Areata Center of Excellence

Study provides new understanding of how memory works when the brain sees a familiar face

UQ researchers discover a molecule essential for regulating nerve repair

Study identifies two types of brain cells involved in organizing discrete memories

Study to examine the risks for brain disorders from repetitive head impacts in contact sports

Community-based approach to genetic testing may have beneficial effects, study finds

Novel MRI approach can identify brain cell damage in people at early stages of Alzheimer's

Aggressive brain tumor in children can be identified by analyzing cerebrospinal fluid

Researchers develop new precision medicine technology for cancer immunotherapy

Mapping cells to understand vascular disease

Study reveals the various ways patients with multiple sclerosis acquire disability

Blood pressure rose moderately during the pandemic, study says

The 'Ross procedure' may be a more favorable option for aortic valve replacement in younger adults

Pioneering treatment for stroke due to intracerebral hemorrhage

Studies compare endovascular therapy and microsurgery for treating wide-neck aneurysms

Neuroscience - Third Edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News